Total Payments
$904.65
2024 Payments
$330.78
Companies
11
Transactions
43
Payment Breakdown by Category
Food & Beverage$807.45 (89.3%)
Education$97.20 (10.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $807.45 | 21 | 89.3% |
| Education | $97.20 | 22 | 10.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Mirum Pharmaceuticals, Inc. | $273.53 | 7 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $179.27 | 3 | $0 (2024) |
| Gilead Sciences, Inc. | $135.43 | 3 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $76.98 | 3 | $0 (2023) |
| Retrophin, Inc. | $76.80 | 19 | $0 (2019) |
| GENZYME CORPORATION | $48.52 | 1 | $0 (2024) |
| ABBVIE INC. | $47.03 | 2 | $0 (2022) |
| Alexion Pharmaceuticals, Inc. | $28.39 | 1 | $0 (2019) |
| COLOPLAST CORP | $22.04 | 1 | $0 (2024) |
| Celltrion USA Inc. | $13.27 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $330.78 | 9 | Regeneron Healthcare Solutions, Inc. ($125.93) |
| 2023 | $106.13 | 4 | Regeneron Healthcare Solutions, Inc. ($53.34) |
| 2022 | $341.18 | 7 | Mirum Pharmaceuticals, Inc. ($168.86) |
| 2021 | $3.39 | 2 | Travere Therapeutics, Inc. ($3.39) |
| 2019 | $91.39 | 12 | Retrophin, Inc. ($45.02) |
| 2018 | $28.20 | 4 | Retrophin, Inc. ($28.20) |
| 2017 | $3.58 | 5 | Retrophin, Inc. ($3.58) |
All Payment Transactions
43 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | In-kind items and services | $25.13 | General |
| Category: Alagille syndrome | ||||||
| 11/08/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $125.93 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/22/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/12/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: Alagille syndrome | ||||||
| 08/27/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.35 | General |
| 08/02/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | In-kind items and services | $27.61 | General |
| Category: Alagille syndrome | ||||||
| 06/18/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | In-kind items and services | $27.17 | General |
| Category: Alagille syndrome | ||||||
| 03/13/2024 | COLOPLAST CORP | Peristeen (Device) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: Continence Care | ||||||
| 01/31/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $48.52 | General |
| Category: Immunology | ||||||
| 10/24/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $27.82 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/11/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.79 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/04/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.55 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 03/28/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/04/2022 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | In-kind items and services | $132.00 | General |
| Category: Alagille syndrome | ||||||
| 07/26/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $4.46 | General |
| 07/21/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $29.05 | General |
| Category: IMMUNOLOGY | ||||||
| 06/01/2022 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/17/2022 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $114.62 | General |
| Category: HCV | ||||||
| 05/10/2022 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: Alagille syndrome | ||||||
| 05/10/2022 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Education | In-kind items and services | $17.01 | General |
| Category: Alagille syndrome | ||||||
| 03/09/2021 | Travere Therapeutics, Inc. | Cholbam (Drug) | Education | In-kind items and services | $0.83 | General |
| Category: Hepatology | ||||||
| 03/03/2021 | Travere Therapeutics, Inc. | Cholbam (Drug) | Education | In-kind items and services | $2.56 | General |
| Category: Hepatology | ||||||
| 12/18/2019 | Retrophin, Inc. | (820) Cholbam (Drug) | Education | In-kind items and services | $4.74 | General |
| Category: Hepatology | ||||||
| 10/17/2019 | Retrophin, Inc. | (820) Cholbam (Drug) | Education | In-kind items and services | $0.83 | General |
| Category: Hepatology | ||||||
| 06/19/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Immunology | ||||||
About Dr. Karan Emerick, MD
Dr. Karan Emerick, MD is a Pediatric Transplant Hepatology healthcare provider based in Hartford, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1750339545.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Karan Emerick, MD has received a total of $904.65 in payments from pharmaceutical and medical device companies, with $330.78 received in 2024. These payments were reported across 43 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($807.45).
Ad
Practice Information
- Specialty Pediatric Transplant Hepatology
- Other Specialties Pediatric Gastroenterology, Pediatric Gastroenterology
- Location Hartford, CT
- Active Since 05/04/2006
- Last Updated 03/07/2023
- Taxonomy Code 2080T0004X
- Entity Type Individual
- NPI Number 1750339545
Products in Payments
- Livmarli (Drug) $273.53
- DUPIXENT (Biological) $227.79
- Epclusa (Drug) $114.62
- GATTEX (Drug) $76.98
- (820) Cholbam (Drug) $76.80
- SKYRIZI (Biological) $29.05
- SOLIRIS (Drug) $28.39
- Peristeen (Device) $22.04
- Humira (Biological) $17.98
- ZYMFENTRA (Biological) $13.27
- Cholbam (Drug) $3.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.